Antiestrogenic Potency of Toremifene and Tamoxifen in Postmenopausal Women
Howard D. Homesley(Mount Sinai Beth Israel), C. Lyden(Mount Sinai Beth Israel), Richard C. Bump(Mount Sinai Beth Israel), Peter G. Hickox(Mount Sinai Beth Israel), Robert W. Rebar(University of California San Diego), Jerry Lovelace(Mount Sinai Beth Israel), Robert V. O’Toole(Walter Reed National Military Medical Center), Anne Colston Wentz(Mount Sinai Beth Israel), Diane S. Harry(Mount Sinai Beth Israel), Irving Shemano, Thomas J. Mullin(Mount Sinai Beth Israel), Richard A. Gams(Breast Center)
Cited by 32
Related Papers
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
|Journal of Clinical Oncology|1997|652
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
|Journal of Clinical Investigation|1976|619
2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions
|Journal of Orthopaedic Research®|2019|313
A common progenitor for human myeloid and lymphoid cells
|Nature|1978|277
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
|Journal of Clinical Oncology|1997|269